Evaluation and Management of Hyperpigmented Palpable Nodules on Ankle and Gluteal Region
Any hyperpigmented palpable lesion on the ankle and gluteal region requires immediate biopsy to exclude melanoma, as these locations can harbor malignant lesions that masquerade as benign conditions.
Initial Diagnostic Approach
The primary concern with hyperpigmented palpable nodules in these locations is melanoma, which must be ruled out first. Perform a full-thickness excisional biopsy or punch biopsy of the most suspicious lesion immediately 1. Do not delay biopsy for imaging or laboratory work-up in the initial evaluation.
Key Clinical Features to Document:
- Size and growth pattern: Rapidly enlarging lesions (>6mm or changing over weeks-months) are concerning
- Surface characteristics: Ulceration, bleeding, or irregular borders suggest malignancy
- Color variation: Multiple colors within a single lesion or very dark pigmentation
- Palpation findings: Firm, fixed nodules versus mobile, soft lesions
- Number of lesions: Solitary versus multiple (multiple lesions may suggest benign conditions like hidradenomas or congenital nevi)
- Duration: Present since birth versus acquired
Differential Diagnosis Framework
Malignant (Must Exclude First):
- Melanoma: Can present as hyperpigmented nodules on acral sites 1
- Nodular melanoma particularly concerning on lower extremities
Benign Considerations:
- Nodular hidradenoma: Rare on lower extremities, difficult to differentiate clinically from melanoma 2
- Giant congenital melanocytic nevus with proliferative nodules: If present since birth with satellite lesions 3
- Dermatofibroma: Common on lower legs, typically firm and hyperpigmented
- Prurigo nodularis: Multiple intensely pruritic nodules, but typically not isolated to ankle/gluteal region 4
Biopsy Technique
For lesions suspicious for melanoma, perform excisional biopsy with 1-2mm clinical margins and full-thickness down to subcutaneous fat 1. This allows complete histopathologic assessment including Breslow depth. If the lesion is too large for excisional biopsy, perform a full-thickness punch biopsy of the thickest or most suspicious area.
Critical Pitfall to Avoid:
Never perform shave biopsies on pigmented nodular lesions—this prevents accurate Breslow depth measurement if melanoma is present and compromises staging 1.
Post-Biopsy Management Algorithm
If Melanoma Confirmed:
Wide local excision with appropriate margins based on Breslow depth 1:
- In situ: 0.5-1 cm margins
- ≤1 mm: 1 cm margins
- 1.01-2 mm: 1-2 cm margins
2 mm: 2 cm margins
Consider sentinel lymph node biopsy for melanomas >0.8mm depth or with high-risk features 1
Refer to multidisciplinary melanoma team for stage IIB or higher 1
If Benign Lesion Confirmed:
- Hidradenoma: Complete surgical excision with clear margins 2
- Congenital nevus with proliferative nodules: Surgical excision, neurological follow-up if giant nevus present 3
- Dermatofibroma: Observation acceptable if diagnosis certain; excision if symptomatic
Imaging and Laboratory Work-Up
Do not obtain imaging or laboratory tests before biopsy—these do not change the need for tissue diagnosis and delay definitive management. After melanoma diagnosis, staging imaging (CT chest/abdomen/pelvis or PET-CT) is indicated only for stage IIB or higher 1.
Special Considerations
The ankle and gluteal regions present unique challenges:
- Acral melanomas (ankle) have worse prognosis and different biology than trunk melanomas
- Surgical margins on the ankle may require skin grafting or flap reconstruction
- Gluteal lesions may be missed during self-examination, leading to delayed presentation
Dermoscopy should be used during initial examination to improve diagnostic accuracy, but never replaces biopsy for definitive diagnosis 5.